Oral edaravone ameliorates myocardial fibrosis in type 2 diabetic rats by TGF-β1/Smad signaling pathway

被引：0
|
作者：
Zhang, Xiao-Yan [1 ]
Xu, Yong-xuan [1 ]
Xue, Si-Quan [2 ]
Zeng, Yue-Qin [2 ]
Gu, Juan-Hua [2 ]
Zhou, Xin-Fu [3 ,4 ]
Luo, Hai-Yun [1 ,5 ]
Pu, Li-Jin [1 ,6 ]
机构：
[1] Kunming Med Univ, Affiliated Hosp 1, Fac Basic Med Sci, Dept Cardiol, 296 Xichang Rd, Kunming 650032, Peoples R China
[2] Biomed Engn Res Ctr, Yunnan Key Lab Stem Cells & Regenerat Med, 1168 Chunrong West Rd, Kunming 650500, Peoples R China
[3] Suzhou Auzone Biotech, Suzhou, Peoples R China
[4] Univ South Australia, Hlth & Biomed Innovat, Clin & Hlth Sci, 101 Currie St, Adelaide 5001, Australia
[5] Kunming Med Univ, Fac Basic Med Sci, 1168 Chunrong West Rd, Kunming 650500, Peoples R China
[6] Kunming Med Univ, Affiliated Hosp 1, 296 Xichang Rd, Kunming 650032, Peoples R China
来源：
JOURNAL OF DIABETES AND ITS COMPLICATIONS | 2025年 / 39卷 / 03期
关键词：
TGF-beta 1/Smad signaling pathway; Edaravone; Myocardial fibrosis; Type 2 diabetes mellitus; GROWTH-FACTOR-BETA; OXIDATIVE STRESS; CARDIAC FIBROSIS; CARDIOMYOPATHY; ANTIOXIDANT; AUTOPHAGY; DAMAGE; SCAR;
D O I：
10.1016/j.jdiacomp.2025.108976
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Myocardial fibrosis, characterized by increased reactive oxygen species (ROS), is a key pathological feature of diabetic cardiomyopathy (DCM). Although oral edaravone (EDA) shows therapeutic potential in ameliorating myocardial fibrosis in DCM, the precise mechanisms remain unclear. Transcriptome analysis of myocardial tissues revealed a dramatic up-regulation of the TGF-(31/Smad pathway, which was reversed by oral EDA treatment. In vitro studies showed that oral EDA attenuated myocardial fibrosis by inhibiting the TGF-(31/Smad signaling pathway and its downstream fibrosis key factors, Col3a1 and a-SMA. These findings suggest that oral EDA improves myocardial fibrosis in Type 2 diabetes mellitus (T2DM) by inhibiting the TGF-(31/Smad signaling pathway and holds promise as an effective treatment for myocardial fibrosis in DCM.
引用
收藏
页数：11
相关论文
共 50 条
  • [1] Evodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway
    Yang, Dongmei
    Li, Li
    Qian, Shanjun
    Liu, Lixin
    JOURNAL OF NATURAL MEDICINES, 2018, 72 (01) : 145 - 154
  • [2] Evodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway
    Dongmei Yang
    Li Li
    Shanjun Qian
    Lixin Liu
    Journal of Natural Medicines, 2018, 72 : 145 - 154
  • [3] Irbesartan ameliorates myocardial fibrosis in diabetic cardiomyopathy rats by inhibiting the TGFβ1/Smad2/3 pathway
    Zong, Min
    Zhao, Hua
    Li, Qiang
    Li, Yanbing
    Zhang, Jianjun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (05)
  • [4] Emodin ameliorates renal fibrosis in rats via TGF-β1/Smad signaling pathway and function study of Smurf 2
    Ma, Libin
    Li, Hua
    Zhang, Shuchao
    Xiong, Xiaoling
    Chen, Kean
    Jiang, Peiwu
    Jiang, Kang
    Deng, Gang
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (02) : 373 - 382
  • [5] Emodin ameliorates renal fibrosis in rats via TGF-β1/Smad signaling pathway and function study of Smurf 2
    Libin Ma
    Hua Li
    Shuchao Zhang
    Xiaoling Xiong
    Kean Chen
    Peiwu Jiang
    Kang Jiang
    Gang Deng
    International Urology and Nephrology, 2018, 50 : 373 - 382
  • [6] Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway
    Yingwen Bai
    Lulu Wang
    Lingyun TingYang
    Weihong Wang
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 2379 - 2391
  • [7] Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway
    Bai, Yingwen
    Wang, Lulu
    Yang, Ting
    Wang, Lingyun
    Ge, Weihong
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (10) : 2379 - 2391
  • [8] Lapatinib ameliorates skin fibrosis by inhibiting TGF-β1/Smad and non-Smad signaling pathway
    Wang, Yongping
    Zhang, Tiantian
    Song, Hao
    Yang, Cheng
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [9] Effect of alprostadil on myocardial fibrosis in rats with diabetes mellitus via TGF-β1/Smad signaling pathway
    Tu, J-H.
    Xu, Y.
    Dai, Y.
    Dang, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (21) : 9633 - 9641
  • [10] Fasudil attenuates myocardial fibrosis in rats with diabetes mellitus via TGF-β1/Smad signaling pathway
    Zhang, Peng
    Wang, Fei
    Song, Jia
    Su, Fangju
    Liu, Yan
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (10) : 233 - 238
12345